RDY financial statements

The full income statement, balance sheet, and cash-flow statement for Dr. Reddy's Laboratories Ltd (RDY), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2018-03 829.6M2019-03 830.3M2020-03 830.9M2021-03 831.5M2022-03 832.1M2023-03 832.6M2024-03 834.1M2025-03 834.5M2026-03 834.7M+0.6% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeYoYQoQFiguresAs-reported fiscal years.

Line item	FY2026	FY2025	FY2024	FY2023	FY2022
Income Statement	as ofMar 31 ’26	as ofMar 31 ’25	as ofMar 31 ’24	as ofMar 31 ’23	as ofMar 31 ’22
Revenue	3.58B YoY-6.1%	3.81B YoY+13.8%	3.35B YoY+12.0%	2.99B YoY+5.9%	2.83B YoY+8.9%
	1.89B YoY-15.3%	2.23B YoY+13.6%	1.96B YoY+15.8%	1.70B YoY+13.0%	1.50B YoY+6.5%
Cost of revenue	1.69B YoY+7.0%	1.58B YoY+14.0%	1.39B YoY+7.0%	1.30B YoY-2.2%	1.32B YoY+11.8%
Research & development	256M YoY-20.0%	320M YoY+16.8%	274M YoY+16.1%	236M YoY+2.6%	230M YoY+1.8%
Operating income	539M YoY-36.0%	842M YoY+3.6%	813M YoY+17.0%	695M YoY+78.7%	389M YoY+17.2%
Interest expense	40.0M YoY+21.2%	33.0M YoY+57.1%	21.0M YoY+23.5%	17.0M YoY+30.8%	13.0M YoY+0.0%
Pre-tax income	584M YoY-35.1%	900M YoY+4.4%	862M YoY+17.4%	734M YoY+72.3%	426M YoY+18.0%
Income tax	132M YoY-42.4%	229M YoY+18.0%	194M YoY+4.3%	186M YoY+61.7%	115M YoY-8.0%
	452M YoY-32.6%	671M YoY+0.4%	668M YoY+21.9%	548M YoY+76.2%	311M YoY+31.8%
Net income to common	456M YoY-31.2%	663M YoY-1.4%	673M YoY+19.9%	561M	—
	$0.55 YoY-30.4%	$0.79 YoY-1.5%	$0.80 YoY+21.5%	$0.66 YoY+76.5%	$0.37 YoY+23.0%
EPS (basic)	$0.55 YoY-30.4%	$0.79 YoY-1.7%	$0.80 YoY+21.8%	$0.66 YoY+76.5%	$0.37 YoY+31.7%
	832M YoY-0.1%	833M YoY+0.1%	832M YoY+0.2%	830M YoY+0.1%	829M YoY+0.0%
	833M YoY-0.1%	834M YoY+0.1%	834M YoY+0.2%	832M YoY+0.0%	832M YoY+0.0%
Dividends per share	$0.09 YoY-4.3%	$0.09 YoY-2.2%	$0.10 YoY-74.1%	$0.37 YoY+456.5%	$0.07 YoY-0.4%
Balance Sheet	as ofMar 31 ’26	as ofMar 31 ’25	as ofMar 31 ’24	as ofMar 31 ’23	as ofMar 31 ’22
	3.22B YoY+9.9%	2.93B YoY-1.6%	2.98B YoY+18.2%	2.52B YoY+5.0%	2.40B YoY+18.3%
Cash & equivalents	164M YoY-4.7%	172M YoY+102.4%	85.0M YoY+21.4%	70.0M YoY-64.3%	196M YoY-3.4%
Accounts receivable	1.08B YoY+2.0%	1.06B YoY+9.9%	963M YoY+9.2%	882M YoY+0.2%	880M YoY+29.6%
Inventory	816M YoY-1.9%	832M YoY+9.0%	763M YoY+28.9%	592M YoY-11.8%	671M YoY+8.1%
	6.17B YoY+7.0%	5.77B YoY+24.1%	4.65B YoY+18.7%	3.92B YoY+1.5%	3.86B YoY+6.3%
Property, plant & equipment	1.24B YoY+8.0%	1.14B YoY+23.9%	923M YoY+14.1%	809M YoY-1.2%	819M YoY+4.9%
Goodwill	137M YoY-0.7%	138M YoY+170.6%	51.0M YoY-1.9%	52.0M YoY-10.3%	58.0M YoY-6.5%
Total non-current assets	2.96B YoY+3.9%	2.84B YoY+70.0%	1.67B YoY+19.7%	1.40B YoY-4.4%	1.46B YoY-8.7%
	1.79B YoY+17.0%	1.53B YoY+32.6%	1.15B YoY+10.3%	1.04B YoY-15.7%	1.24B YoY+8.7%
Short-term & current debt	64.0M YoY+540.0%	10.0M YoY-37.5%	16.0M YoY-72.4%	58.0M YoY+346.2%	13.0M YoY+8.3%
	2.12B YoY+16.2%	1.82B YoY+42.1%	1.28B YoY+16.1%	1.11B YoY-18.0%	1.35B YoY+6.6%
Long-term debt	130M YoY+41.3%	92.0M YoY+27.8%	72.0M YoY+350.0%	16.0M YoY-78.9%	76.0M YoY-11.6%
	4.02B YoY+2.9%	3.90B YoY+15.9%	3.37B YoY+19.8%	2.81B YoY+11.9%	2.51B YoY+6.1%
Total equity incl. non-controlling	4.05B YoY+2.7%	3.95B YoY+17.3%	3.37B YoY+19.8%	2.81B YoY+11.9%	2.51B YoY+6.1%
	835M YoY+0.0%	834M YoY+0.0%	834M YoY+0.2%	833M YoY+0.1%	832M YoY+0.1%
Cash Flow	as ofMar 31 ’26	as ofMar 31 ’25	as ofMar 31 ’24	as ofMar 31 ’23	as ofMar 31 ’22
	607M YoY+11.4%	545M YoY+0.0%	545M YoY-23.9%	716M YoY+93.5%	370M YoY-24.2%
Depreciation & amortization	233M YoY+15.6%	202M YoY+12.5%	179M YoY+13.9%	157M YoY-0.9%	159M YoY-7.9%
Intangible amortization	90.3M YoY+16.6%	77.4M YoY+21.8%	63.6M YoY+27.0%	50.1M YoY+1.6%	49.3M YoY-14.3%
Acquisitions	0.00	0.00	0.00	0.00	0.00
Long-term debt issued	1.35B YoY+42.2%	953M YoY+307.4%	234M YoY-61.8%	613M YoY-11.4%	692M YoY+6.4%
Long-term debt repaid	1.13B YoY+69.7%	664M YoY+296.0%	168M YoY-80.4%	854M YoY+32.6%	644M YoY+15.5%
Common stock issued	0.00 YoY-100.0%	83.4M	0.00	0.00	0.00
Common stock repurchased	0.00 YoY-100.0%	16.4M	0.00	0.00	0.00
Dividends paid	75.3M YoY-4.4%	78.7M YoY-2.0%	80.3M YoY+29.5%	62.0M YoY+11.4%	55.7M YoY-0.4%
Valuation Ratios	as ofMar 31 ’26	as ofMar 31 ’25	as ofMar 31 ’24	as ofMar 31 ’23	as ofMar 31 ’22
Market cap	11.6B YoY+5.0%	11.0B YoY-9.9%	12.2B YoY+28.8%	9.48B YoY+2.2%	9.27B YoY-9.2%
P/E	25.6× YoY+55.9%	16.4× YoY-26.4%	22.3× YoY+28.8%	17.3× YoY-42.0%	29.8× YoY-31.1%
P/S	3.2× YoY+11.8%	2.9× YoY-29.3%	4.1× YoY+28.8%	3.2× YoY-3.5%	3.3× YoY-16.6%
P/B	2.9× YoY+2.0%	2.8× YoY-35.1%	4.3× YoY+28.8%	3.4× YoY-8.7%	3.7× YoY-14.4%
	3.9% YoY-35.9%	6.1% YoY+35.9%	4.5% YoY-22.4%	5.8% YoY+72.4%	3.4% YoY+45.1%
	0.65% YoY-8.9%	0.72% YoY+8.8%	0.66% YoY-79.9%	3.3% YoY+444.7%	0.60% YoY+9.8%
Source filing	20-F	20-F	20-F	20-F	20-F

About this data

Source: RDY's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all RDY filings on SEC EDGAR → Not investment advice.